HANDLE HRR NGS Panel

AR, ATM, ATR, BARD1, BRCA1, BRCA2, BRIP1, CDH1, CDK12, CHEK1, CHEK2, ESR1, FANCA, FANCL, HDAC2, HOXB13, MRE11A, NBN, PALB2, PPP2R2A, PTEN, RAD51B, RAD51C, RAD51D, RAD54L, STK11, TP53, BRAF, ERBB2, KRAS, NRAS, PIK3CA

NGS
NGS Assays
Features
Sample
Type
- whole blood & fresh frozen/FFPE tissue
1
- whole blood & fresh frozen/FFPE tissue
Mutation Type
- detect SNV/InDel
2
- detect SNV/InDel
Turn-around Time
- 5h TAT and 1h hands on time
3
- 5h TAT and 1h hands on time
Product Description

Background
The Homologous Recombination Repair (HRR) pathway plays an important role in double strand break, which is the major cause of cancer development. It has been demonstrated that loss of function of HRR genes (e.g. BRCA1, BRCA2, PALB2) and Homologous Recombination Deficiency (HRD) will cause a higher risk of developing cancer, and patients with HRR gene mutations showed higher response to PARPi and platinum-containing therapies. 


Figure 1*. DNA Repair Pathways

Intended Use
The AmoyDx® HANDLE HRR NGS Panel (Reversible Terminator Sequencing), is intended for qualitative detection of AR, ATM, ATR, BARD1, BRCA1, BRCA2, BRIP1, CDH1, CDK12, CHEK1, CHEK2, ESR1, FANCA, FANCL, HDAC2, HOXB13, MRE11A, NBN, PALB2, PPP2R2A, PTEN, RAD51B, RAD51C, RAD51D, RAD54L, STK11 and TP53 variants (in coding exons and exon-intron boundaries) and hotspots of gene BRAF, ERBB2, KRAS, NRAS and PIK3CA in extracted DNA from human blood samples, fresh tissue or neutral formalin-fixed paraffin-embedded (FFPE) tissue samples. The detected variants include point mutations, small insertions and deletions in HRR genes.
The kit is for research use only, and intended to be used by trained professionals in a laboratory environment.

Principles of the Procedure
The test kit is based on Halo-shape ANnealing and Defer-Ligation Enrichment system (HANDLE system) technology which is improved Molecular Inversion Probe (MIP) technology to capture the target gene region (Figure 1). The unique molecular identifier (UID) is introduced to both end of each DNA fragment, and tracing back to original template for error correction. The library construction time of HANDLE system is 5 hours with 1 hour hands-on time. After quality control (QC), the prepared DNA libraries are sequenced on Illumina sequencing platform to detect the mutations from 32 HRR related genes mentioned above.


Figure 2. Principle of library construction (HANDLE system)

The probe contains an extension arm and a ligation arm which are complementary to the target gene region. First, the extension arm and ligation arm are anchored to the target gene region, and the DNA is extended from the extension arm to the ligation arm by the function of DNA polymerase. Next, the nicks are connected with the ligase to generate the circular products. The remaining linear probes, single-strand and double-strand nucleic acid are digested with the exonuclease. Finally, the universal PCR amplification is performed to enrich the target libraries.

*Pilié P G, Tang C, Mills G B, et al. State-of-the-art strategies for targeting the DNA damage response in cancer[J]. Nature Reviews Clinical Oncology, 2019, 16(2): 81-104.

Testing Procedure
Compatible Sample Types:Whole Blood & Fresh Frozen/FFPE Tissue
Compatible NGS Instrument
iSeq 100
Miseq
MiniSeq
Miseq Dx
NextSeq
HiSeq Series
NovaSeq
Other Info.

To order, please contact sales@amoydx.com.
AmoyDx HANDLE HRR NGS Panel is available in the following size.

 Product Name Size (test/kit)  Storage  Cat. No.
AmoyDx HANDLE HRR NGS Panel 24T -20℃ 8.0680701X024I
Certificate
BACK
Inquiry
Inquiry
* Required information
Manage your account info
Change your password